NCT06663618

Short-term Glucocorticoid Combined with MMF for IgG4-RD

Comparison of Short-term Glucocorticoid Monotherapy and Short-term Glucocorticoid Combined with Mycophenolate Mofetil in the Treatment of IgG4 Related Disease

• Status: Recruiting
• Phase: N/A
• Study type: Interventional
• Enrollment: 63 (estimated)
• Sponsor: Wen Zhang · Academic / Other
• Sex: All
• Age: 18 Years – 80 Years
• Healthy volunteers: Not accepted

Summary

Comparison of short-term glucocorticoid monotherapy and short-term glucocorticoid combined with MMF in the treatment of IgG4 Related Disease

Detailed description

This is a monocenter, 72-week prospective, randomized controlled study to compare short-term glucocorticoid monotherapy and short-term glucocorticoid combined with MMF in the treatment of IgG4 Related Disease.

Conditions

• IgG4-related Disease

Interventions

Type	Name	Description
DRUG	prednison	Oral prednison starts at 0.6-0.8mg/kg/d, then tapered and withdrawal in 6 months.
DRUG	Mycophenolate mofetil	Oral Mycophenolate mofetil 0.75g bid for 6 months.

Timeline

• Start date: 2023-09-01
• Primary completion: 2025-03-01
• Completion: 2025-09-01
• First posted: 2024-10-29
• Last updated: 2024-10-29

Locations

1 site across 1 country: China